VCEL
VCEL
NASDAQ · Biotechnology

Vericel Corp

$32.45
+1.04 (+3.31%)
As of Mar 23, 10:02 PM ET ·
Financial Highlights (FY 2026)
Revenue
253.55M
Net Income
15.16M
Gross Margin
74.4%
Profit Margin
6.0%
Rev Growth
+18.9%
D/E Ratio
0.01
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 74.4% 74.4% 63.7% 63.7%
Operating Margin 4.0% 3.6% 26.5% 24.7%
Profit Margin 6.0% 5.7% 22.8% 17.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 253.55M 213.27M 156.14M 179.63M
Gross Profit 188.69M 158.71M 99.49M 114.46M
Operating Income 10.14M 7.68M 41.33M 44.36M
Net Income 15.16M 11.48M 35.53M 31.27M
Gross Margin 74.4% 74.4% 63.7% 63.7%
Operating Margin 4.0% 3.6% 26.5% 24.7%
Profit Margin 6.0% 5.7% 22.8% 17.4%
Rev Growth +18.9% +18.9% +24.7% +19.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 4.66M 4.66M 622.73M 660.37M
Total Equity 818.36M 818.36M 997.81M 1.08B
D/E Ratio 0.01 0.01 0.62 0.61
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 20.69M 16.53M 44.60M 53.31M
Free Cash Flow 32.60M 24.70M